Leadership Team
Meet our experienced team.
Schedule a meeting with our team of Dr Campbell Bunce, Chief Scientific Officer, Parviz Ayai Shamlou, Sr. Vice President of Science and Technology, Craig Magee, Vice President of Business Development, and Zoe Yi Zhang, Vice President of Business Development to connect on your project-specific needs and to provide you with an update on our expanded global capabilities.
From antibodies (mAbs) to recombinant vaccines and bioconjugates including antibody-drug conjugates (ADCs), radioconjugates, and oligonucleotides, our team appreciates the chance to share how Abzena can assist in moving your program forward faster to its next milestone.
Don’t miss our two poster presentations titled ‘EpiScreen® 2.0 Time Course Assay: A Sensitive and Data-Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics’ and ‘Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager.’ Please check back in September for location and times.